News & Updates

Older diabetic patients with acute heart failure who undergo physical rehabilitation have worse baseline physical function but demonstrate similar clinically meaningful improvements from the intervention, results of the Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial have shown. However, the benefit derived for frailty is lesser among those with diabetes.

Cardiac rehabilitation is standard for the treatment of heart failure (HF) and yields short-term prognostic benefits, a recent study has found. However, long-term benefits remain uncertain.

Differential changes in fasting serum levels of fibroblast growth factor (FGF)-19 and FGF-21 may help account for the superior cardiovascular benefit of bariatric surgery on obese patients with type 2 diabetes mellitus vs nondiabetics, a recent study has found.

Women who have experienced miscarriage and stillbirth are at higher risk of stroke, as suggested in a recent meta-analysis.

Antihypertensive therapy (AHT) may be used safely during the COVID-19 pandemic, as no evidence suggest that it can increase the risk of SARS-CoV-2 infection or death, according to a UK study. In addition, most classes of antihypertensives are negatively associated with COVID-19 diagnosis.

There appears to be genetic evidence that depression contributes to an increased risk of coronary artery disease in patients with diabetes, as shown in the results of a Mendelian randomization study.